IP Verse

Neymeyr patent opposition analysis

CompanyCompetitive AnalysisCompany Patent Opposition Analysis

Latest oppositions filed by Neymeyr

Explore patent oppositions filed by Neymeyr against competitors, revealing strategic technology disputes and market positioning. Monitor opposition details, timelines, and disputed innovations to understand competitive dynamics and IP enforcement strategy.

Last updated on: Aug 14, 2025
Patent NumberTitleApplicantOpposition Date

Get instant updates on new opposition filings by the company

EP4321157
New Use Of A Combination Of An Angiotensin Receptor Blocker (Arb) With A Neutral Endopeptidase Inhibitor (Nepi)NOVARTISJul 16, 2025
EP4125903
Methods For Dose Initiation Of Aripiprazole TreatmentsOTSUKA PHARMACEUTICALJul 1, 2025
EP4097091
Solid State Forms Of Mavacamten And Process For Preparation ThereofASSIA CHEMICAL INDUSTRIESJun 17, 2025
EP4041186
An Anhydrous Pharmaceutical Composition For Maintenance Treatment Of PsoriasisLEO PHARMAFeb 17, 2025
EP3373972
Compositions For Treating Spinal Muscular AtrophyF HOFFMANN LA ROCHEDec 20, 2024
EP3820625
Device For Dispensing A Fluid Product, And Method For Filling And For Plugging SameAPTAR FRANCEDec 12, 2024
EP3626270
New UseNOVARTISJul 10, 2024
EP3294283
Sacubitril-Valsartan Dosage Regimen For Treating Heart FailureNOVARTISNov 30, 2023
EP3067043
Pharmaceutical Compositions Based On Superstructures Of Angiotensin Receptor Antagonist/Blocker (Arb) And Neutral Endopeptidase (Nep) InhibitorNOVARTISAug 24, 2023
EP3448416
Semaglutide In Cardiovascular ConditionsNOVO NORDISKMay 10, 2023

Top competitors of Neymeyr

Top competitors of Neymeyr based on patent oppositions.